FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

346346004: Betamethasone+neomycin sulfate (product)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2006. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    470504010 Betamethasone+neomycin sulphate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    470505011 Betamethasone+neomycin sulfate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1193393010 Betamethasone+neomycin sulfate (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Betamethasone+neomycin sulfate Is a Product containing betamethasone in topical dosage form false Inferred relationship Some
    Betamethasone+neomycin sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Betamethasone false Inferred relationship Some
    Betamethasone+neomycin sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Adrenal hormone false Inferred relationship Some
    Betamethasone+neomycin sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Corticosterone false Inferred relationship Some
    Betamethasone+neomycin sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Adrenal hormone agent false Inferred relationship Some
    Betamethasone+neomycin sulfate Is a Product containing neomycin (medicinal product) false Inferred relationship Some
    Betamethasone+neomycin sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. anti-infectieux cutané false Inferred relationship Some
    Betamethasone+neomycin sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Neomycin (substance) false Inferred relationship Some
    Betamethasone+neomycin sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Glucocorticoid hormone false Inferred relationship Some
    Betamethasone+neomycin sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bactericide false Inferred relationship Some
    Betamethasone+neomycin sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Local anti-infective false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) Is a False Betamethasone+neomycin sulfate Inferred relationship Some
    Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) Is a False Betamethasone+neomycin sulfate Inferred relationship Some
    Betamethasone (as betamethasone valerate) 1 mg/g and neomycin sulfate 5 mg/g cutaneous ointment Is a False Betamethasone+neomycin sulfate Inferred relationship Some
    Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) Is a False Betamethasone+neomycin sulfate Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    SAME AS association reference set (foundation metadata concept)

    Back to Start